These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29147862)

  • 21. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
    Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
    Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration.
    Finkelstein F; Healy H; Abu-Alfa A; Ahmad S; Brown F; Gehr T; Nash K; Sorkin M; Mujais S
    J Am Soc Nephrol; 2005 Feb; 16(2):546-54. PubMed ID: 15625070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
    García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The peritoneal-renal syndrome.
    Nessim SJ; Bargman JM
    Nat Rev Nephrol; 2013 May; 9(5):302-6. PubMed ID: 23507827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Icodextrin-induced acute pancreatitis in a peritoneal dialysis patient: a case report and literature review
.
    Rubinstein S; Franjul R; Surana S; Fogel J
    Clin Nephrol; 2016 Nov; 86 (2016)(11):283-286. PubMed ID: 27616762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials.
    Qi H; Xu C; Yan H; Ma J
    Perit Dial Int; 2011; 31(2):179-88. PubMed ID: 21119069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials.
    Cho Y; Johnson DW; Badve S; Craig JC; Strippoli GF; Wiggins KJ
    Nephrol Dial Transplant; 2013 Jul; 28(7):1899-907. PubMed ID: 23493329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based medicine in peritoneal dialysis: peritoneal dialysis solutions.
    Feriani M
    Contrib Nephrol; 2003; (140):202-8. PubMed ID: 12800361
    [No Abstract]   [Full Text] [Related]  

  • 29. Icodextrin re-absorption varies with age in children on automated peritoneal dialysis.
    Dart A; Feber J; Wong H; Filler G
    Pediatr Nephrol; 2005 May; 20(5):683-5. PubMed ID: 15719251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal dialysis in patients with diabetes: are the benefits greater than the disadvantages?
    Kuriyama S
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S190-5. PubMed ID: 17556303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Icodextrin metabolites in peritoneal dialysis.
    García-López E; Lindholm B
    Perit Dial Int; 2009; 29(4):370-6. PubMed ID: 19602601
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
    Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
    Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution.
    MacGinley R; Cooney K; Alexander G; Cohen S; Goldsmith DJ
    Am J Kidney Dis; 2002 Nov; 40(5):1030-5. PubMed ID: 12407649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.
    Jenkins SB; Wilkie ME
    Perit Dial Int; 2003; 23(5):475-80. PubMed ID: 14604201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.
    Konings CJ; Kooman JP; Schonck M; Gladziwa U; Wirtz J; van den Wall Bake AW; Gerlag PG; Hoorntje SJ; Wolters J; van der Sande FM; Leunissen KM
    Kidney Int; 2003 Apr; 63(4):1556-63. PubMed ID: 12631373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Trio Trial - A Randomized Controlled Clinical Trial Evaluating the Effect of a Biocompatible Peritoneal Dialysis Solution on Residual Renal Function.
    Sikaneta T; Wu G; Abdolell M; Ng A; Mahdavi S; Svendrovski A; Tu T; Mercer T; Tong M; Oreopoulos D; Tam P
    Perit Dial Int; 2016 9-10; 36(5):526-32. PubMed ID: 27282852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Osmol Gap Hyponatremia Caused by Icodextrin: A Case Series Report.
    de Fijter CWH; Stachowska-Pietka J; Waniewski J; Lindholm B
    Am J Nephrol; 2024; 55(2):202-205. PubMed ID: 37579741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of fill volume on ultrafiltration with icodextrin in children on chronic peritoneal dialysis.
    Rousso S; Banh TM; Ackerman S; Piva E; Licht C; Harvey EA
    Pediatr Nephrol; 2016 Oct; 31(10):1673-9. PubMed ID: 27178072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of relapsing sterile icodextrin-associated peritonitis on peritoneal dialysis outcome.
    Basile C; De Padova F; Montanaro A; Giordano R
    J Nephrol; 2003; 16(3):384-6. PubMed ID: 12832738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Icodextrin: an alternative peritoneal dialysis fluid.
    Chhabra D; Nash K
    Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1455-64. PubMed ID: 18950286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.